“ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS”. Mediterranean Journal of Hematology and Infectious Diseases, vol. 4, no. 1, Nov. 2012, p. e2012072, https://doi.org/10.4084/mjhid.2012.072.